These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9253329)

  • 21. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
    Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.
    Nørrelund H; Vahl N; Juul A; Møller N; Alberti KG; Skakkebaek NE; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 2000 May; 85(5):1912-7. PubMed ID: 10843174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effect of insulin-like growth factor-I administration on the protein-sparing effects of total parenteral nutrition in fasted lambs.
    Koea JB; Douglas RG; Breier BH; Shaw JH; Gluckman PD
    Endocrinology; 1992 Aug; 131(2):643-8. PubMed ID: 1639012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose flux is normalized by compensatory hyperinsulinaemia in growth hormone-induced insulin resistance in healthy subjects, while skeletal muscle protein synthesis remains unchanged.
    Nygren J; Thorell A; Brismar K; Essén P; Wernerman J; McNurlan MA; Garlick PJ; Ljungqvist O
    Clin Sci (Lond); 2002 Apr; 102(4):457-64. PubMed ID: 11914108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined recombinant human growth hormone and recombinant human insulin-like growth factor I: lack of synergy on whole body protein anabolism in normally fed subjects.
    Mauras N
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2633-7. PubMed ID: 7673406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of continuous subcutaneous infusion versus daily subcutaneous injections of growth hormone (GH) on the insulin-like growth factor system, insulin sensitivity, body composition, and bone and lipoprotein metabolism in GH-deficient adults.
    Laursen T; Gravholt CH; Heickendorff L; Drustrup J; Kappelgaard AM; Jørgensen JO; Christiansen JS
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1222-8. PubMed ID: 11238512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
    Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of increasing doses of recombinant human insulin-like growth factor-I on glucose, lipid, and leucine metabolism in man.
    Turkalj I; Keller U; Ninnis R; Vosmeer S; Stauffacher W
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1186-91. PubMed ID: 1430077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
    Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
    Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.
    Mauras N; Martinez V; Rini A; Guevara-Aguirre J
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3036-42. PubMed ID: 10999782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of recombinant human growth hormone on glucose and leucine metabolism in Cushing's syndrome.
    Bowes SB; Umpleby M; Cummings MH; Jackson NC; Carroll PV; Lowy C; Sönksen PH; Russell-Jones DL
    J Clin Endocrinol Metab; 1997 Jan; 82(1):243-6. PubMed ID: 8989267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury.
    Hatton J; Kryscio R; Ryan M; Ott L; Young B
    J Neurosurg; 2006 Dec; 105(6):843-52. PubMed ID: 17405254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short-term effects of growth hormone and insulin-like growth factor I on cancellous bone in rhesus macaque monkeys.
    Sass DA; Jerome CP; Bowman AR; Bennett-Cain A; Ginn TA; LeRoith D; Epstein S
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1202-9. PubMed ID: 9100597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No influence of prednisolone on IGFBP-3 proteolysis in healthy young men.
    Dall R; Wolthers T; Flyvbjerg A; Grøfte T; Sandahl Christiansen J; Jørgensen JO
    Horm Res; 2001; 55(2):95-101. PubMed ID: 11509866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant human insulin-like growth factor-I enhances whole body protein anabolism and significantly diminishes the protein catabolic effects of prednisone in humans without a diabetogenic effect.
    Mauras N; Beaufrere B
    J Clin Endocrinol Metab; 1995 Mar; 80(3):869-74. PubMed ID: 7533772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of growth hormone and/or sex steroid administration on whole-body protein turnover in healthy aged women and men.
    Huang X; Blackman MR; Herreman K; Pabst KM; Harman SM; Caballero B
    Metabolism; 2005 Sep; 54(9):1162-7. PubMed ID: 16125527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men.
    Lange KH; Larsson B; Flyvbjerg A; Dall R; Bennekou M; Rasmussen MH; Ørskov H; Kjaer M
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4966-75. PubMed ID: 12414860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study.
    Tayek JA; Brasel JA
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2082-7. PubMed ID: 7608259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.